Skip to results
Modify your search
NARROW
1-6 of 6
Authors: C. Rabaud
Journal Article
EDITOR'S CHOICE
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial Free
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 3, March 2016, Pages 783–793, https://doi.org/10.1093/jac/dkv384
Published: 17 December 2015
Journal Article
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 6, June 2015, Pages 1816–1824, https://doi.org/10.1093/jac/dkv036
Published: 01 March 2015
Journal Article
Real-life rilpivirine resistance and potential emergence of an E138A-positive HIV strain in north-eastern France Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 11, November 2014, Pages 3095–3102, https://doi.org/10.1093/jac/dku256
Published: 08 July 2014
Journal Article
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 8, August 2011, Pages 1869–1877, https://doi.org/10.1093/jac/dkr208
Published: 01 June 2011
Journal Article
Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 7, July 2011, Pages 1582–1589, https://doi.org/10.1093/jac/dkr153
Published: 27 April 2011
Journal Article
Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy? Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 138–144, https://doi.org/10.1093/jac/dkp402
Published: 10 November 2009
